Impact of Atypical Antipsychotic Use Among Adolescents With Attention-Deficit/Hyperactivity Disorder

To compare treatment patterns, resource utilization, and costs to US third-party payers of stimulant-treated adolescent attention deficit/ hyperactivity disorder (ADHD) patients who switched to or augmented with atypical antipsychotics (AAPs; not FDA-indicated for ADHD) with those who switched to or...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The American journal of managed care 2014-09, Vol.20 (9), p.1
Hauptverfasser:	Sikirica, Vanja, Pliszka, Steven R, Betts, Keith A, Hodgkins, Paul, Samuelson, Thomas M, Xie, Jipan, Erder, M Haim, Dammerman, Ryan S, Robertson, Brigitte, Wu, Eric Q
Format:	Artikel
Sprache:	eng
Schlagworte:	Antipsychotics Attention deficit hyperactivity disorder Health care expenditures Patients Psychotropic drugs Teenagers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!